Genmab — November 2020
-
Kortfattet - værdien af eksisterende 3 produkter, ej udspecificeret, 1500 kr., - værdi af udført forskning/milestone mv. 500 kr. - resterende pipeline 1000 kr.
-
Artiklen giver ikke det store andet end, at Citi er mere positive efter CMD, end før CMD
-
Sry. ! Kan nu se artiklen for 3.
gang er opdateret i løbet af ca. 40-50 min. Skal have læst den igen.... -
Epco er stjernen, værdi 613 DKK per aktie
-
GEN1046 værdi 128 DKK per aktie
-
UBS allokerer GEN1046 en værdi på DKK 50, og Nordea 0
-
Der er ingen tidshorisont nævnt for dette target, så om det er 4, 7 eller 10 år vides ikke...
-
Det er ikke lige i dag vi nærmer os 5000.
-
Moderna: Covid vaccine shows nearly 95% protection https://www.bbc.com/news/health-54902908
-
-
?? Bekymringer om lægemiddelhåb fra Genmab https://finans.dk/erhverv/ECE12564510/bekymringer-om-laegemiddelhaab-fra-genmab/?ctxref=ext
-
GEN1046. I know Nordea are
so far not impressed, they need more evidence about safety -
Seagen R&D Day for the real fans in 30mins https://seagen.zoom.us/webinar/register/WN_1_oN6Fb7Ruyc2_wPxS_JcQ
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind